Low–normal thyroid function and the pathogenesis of common cardio‐metabolic disorders
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Background: Subclinical hypothyroidism may adversely affect the development of cardiovascular disease (CVD). Less is known about the role of low–normal thyroid function, that is higher thyroid‐stimulating hormone and/or lower free thyroxine levels within the euthyroid reference range, in the development of cardio‐metabolic disorders. This review is focused on the relationship of low–normal thyroid function with CVD, plasma lipids and lipoprotein function, as well as with metabolic syndrome (MetS), chronic kidney disease (CKD) and nonalcoholic fatty liver disease (NAFLD). Materials and methods: This narrative review, which includes results from previously published systematic reviews and meta‐analyses, is based on clinical and basic research papers, obtained via MEDLINE and PubMed up to November 2014. Results: Low–normal thyroid function could adversely affect the development of (subclinical) atherosclerotic manifestations. It is likely that low–normal thyroid function relates to modest increases in plasma total cholesterol, LDL cholesterol and triglycerides, and may convey pro‐atherogenic changes in lipoprotein metabolism and in HDL function. Most available data support the concept that low–normal thyroid function is associated with MetS, insulin resistance and CKD, but not with high blood pressure. Inconsistent effects of low–normal thyroid function on NAFLD have been reported so far. Conclusions: Observational studies suggest that low–normal thyroid function may be implicated in the pathogenesis of CVD. Low–normal thyroid function could also play a role in the development of MetS, insulin resistance and CKD, but the relationship with NAFLD is uncertain. The extent to which low–normal thyroid function prospectively predicts cardio‐metabolic disorders has been insufficiently established so far.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Colorado Thyroid Disease Prevalence Study
Canaris, G. J., Manowitz, N. R., Mayor, G., & Ridgway, E. C. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.4.526 · Cited by 2,824
Thyroid hormone and the cardiovascular system.
Klein, I., & Ojamaa, K. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102153440707 · Cited by 2,300
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
Targher, G., Day, C. P., & Bonora, E. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0912063 · Cited by 1,907 · cited 14×
“Accumulating evidence supports an association between NAFLD and increased risk of CVD [84,85], which at least in part independent from an association with CKD [80].”
BackgroundInfluentialThe Clinical Significance of Subclinical Thyroid Dysfunction
Biondi, B., & Cooper, D. S. (2008) · Endocrine Reviews · doi:10.1210/er.2006-0043 · Cited by 1,418 · cited 1×
“5 mU/L), together with a plasma free thyroxine (FT4) level within the reference range, is a well-recognized entity [3].”
BackgroundAdiels, M., Olofsson, S.-O., Taskinen, M.-R., & Borén, J. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.160192 · Cited by 820
Knudsen, N., Laurberg, P., Rasmussen, L. B., Bülow, I., Perrild, H., Ovesen, L., & Jørgensen, T. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2225 · Cited by 753
Duntas, L. H. (2002) · Thyroid · doi:10.1089/10507250252949405 · Cited by 725
Overproduction of large VLDL particles is driven by increased liver fat content in man
Adiels, M., Taskinen, M.-R., Packard, C., Caslake, M. J., Soro-Paavonen, A., Westerbacka, J., Vehkavaara, S., Häkkinen, A., Olofsson, S.-O., Yki-Järvinen, H., et al. (2006) · Diabetologia · doi:10.1007/s00125-005-0125-z · Cited by 690
Andersen, S., Pedersen, K. M., Bruun, N. H., & Laurberg, P. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8165 · Cited by 686 · cited 1×
“higher TSH and/or lower FT4 levels within the euthyroid reference range, even when determined at a single time-point [6], could have a negative impact on cardio-metabolic disorders [1,7].”
BackgroundParle, J. V., Maisonneuve, P., Sheppard, M. C., Boyle, P., & Franklyn, J. A. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06067-6 · Cited by 669 · cited 1×
“On the other hand, a prospective study from the UK among 1191 individuals did not show a significant relationship between (cardiovascular) mortality and variation in TSH levels within the euthyroid reference range, but this survey was primarily focused on subclinical hyperthyroidism [17].”
BackgroundThyroid Function Is Associated with Components of the Metabolic Syndrome in Euthyroid Subjects
Roos, A., Bakker, S. J. L., Links, T. P., Gans, R. O. B., & Wolffenbuttel, B. H. R. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1718 · Cited by 542
Meta-analysis: Subclinical Thyroid Dysfunction and the Risk for Coronary Heart Disease and Mortality
Ochs, N., Auer, R., Bauer, D. C., Nanchen, D., Gussekloo, J., Cornuz, J., & Rodondi, N. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-11-200806030-00225 · Cited by 477 · cited 15×
“Conclusions Observational studies suggest that low–normal thyroid function may be implicated in the pathogenesis of CVD. Low–normal thyroid function could also play a role in the development of MetS, insulin resistance and CKD, but the relationship with NAFLD is uncertain.”
BackgroundInfluentialAoki, Y., Belin, R. M., Clickner, R., Jeffries, R., Phillips, L., & Mahaffey, K. R. (2007) · Thyroid · doi:10.1089/thy.2006.0235 · Cited by 390
Razvi, S., Shakoor, A., Vanderpump, M., Weaver, J. U., & Pearce, S. H. S. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0167 · Cited by 330 · cited 15×
“Conclusions Observational studies suggest that low–normal thyroid function may be implicated in the pathogenesis of CVD. Low–normal thyroid function could also play a role in the development of MetS, insulin resistance and CKD, but the relationship with NAFLD is uncertain.”
BackgroundInfluentialA Review of the Clinical Consequences of Variation in Thyroid Function Within the Reference Range
Taylor, P. N., Razvi, S., Pearce, S. H., & Dayan, C. M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1315 · Cited by 274 · cited 2×
“higher TSH and/or lower FT4 levels within the euthyroid reference range, even when determined at a single time-point [6], could have a negative impact on cardio-metabolic disorders [1,7].”
BackgroundGarduño-Garcia, J. D. J., Alvirde-Garcia, U., López-Carrasco, G., Padilla Mendoza, M. E., Mehta, R., Arellano-Campos, O., Choza, R., Sauque, L., Garay-Sevilla, M. E., Malacara, J. M., et al. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0312 · Cited by 268 · cited 4×
“On the other hand, SCH did neither predict increased prevalence of MetS, nor of its individual components in the Mexican study [26].”
BackgroundMethodInfluentialSingh, S., Duggal, J., Molnar, J., Maldonado, F., Barsano, C. P., & Arora, R. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.02.027 · Cited by 243 · cited 14×
“Conclusions Observational studies suggest that low–normal thyroid function may be implicated in the pathogenesis of CVD. Low–normal thyroid function could also play a role in the development of MetS, insulin resistance and CKD, but the relationship with NAFLD is uncertain.”
BackgroundInfluentialNonalcoholic fatty liver disease
Erickson, S. K. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800089-jlr200 · Cited by 194
Prevalence of hypothyroidism in nonalcoholic fatty liver disease
Pagadala, M. R., Zein, C. O., Dasarathy, S., Yerian, L. M., Lopez, R., & McCullough, A. J. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-2006-2 · Cited by 178 · cited 1×
“5 to 2 times more likely to have biopsy-proven or ultrasonography confirmed NAFLD [90,91].”
BackgroundChronic Kidney Disease as a Coronary Artery Disease Risk Equivalent
Briasoulis, A., & Bakris, G. L. (2013) · Current Cardiology Reports · doi:10.1007/s11886-012-0340-4 · Cited by 152
Subclinical thyroid dysfunction and blood pressure: a community‐based study
Walsh, J. P., Bremner, A. P., Bulsara, M. K., O’Leary, P., Leedman, P. J., Feddema, P., & Michelangeli, V. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02619.x · Cited by 117 · cited 1×
“Both in the Busselton Health study and in the PREVEND study, blood pressure was not significantly associated with low-normal thyroid function [23,68].”
Åsvold, B. O., Bjøro, T., Platou, C., & Vatten, L. J. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04477.x · Cited by 107
Lee, Y. K., Kim, J. E., Oh, H. J., Park, K. S., Kim, S. K., Park, S. W., Kim, M. J., & Cho, Y. W. (2011) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2011.26.4.432 · Cited by 100 · cited 1×
“We retrieved 9 studies comprising > 500 subjects (90041 individuals), which evaluated the effect of low-normal thyroid function on plasma (apo)lipoproteins [16,19,23-29] (Table 3).”
Method
Cited by
Thyroid function and the risk of nonalcoholic fatty liver disease: the Rotterdam study
Bano, A., Chaker, L., Plompen, E. P. C., Hofman, A., Dehghan, A., Franco, O. H., Janssen, H. L. A., Murad, S. D., & Peeters, R. P. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1300 · Cited by 209
“A recent review has also highlighted the need for prospective research on the association between normal thyroid function and NAFLD risk (16).”
BackgroundKim, D., Kim, W., Joo, S. K., Bae, J. M., Kim, J. H., & Ahmed, A. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.08.014 · Cited by 191
Chaker, L., Baumgartner, C., den Elzen, W. P. J., Collet, T.-H., Ikram, M. A., Blum, M. R., Dehghan, A., Drechsler, C., Luben, R. N., Portegies, M. L. P., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2255 · Cited by 92
Self-citation
Metadata
- Authors
- van Tienhoven‐Wind, L. J. N., & Dullaart, R. P. F.
- Venue
- European Journal of Clinical Investigation
- Publisher
- Wiley
- Published
- 2015-03-09
- Volume
- 45
- Issue
- 5
- Pages
- 494-503
- ISSN
- 0014-2972 (ISSN-L)
- 1365-2362
- OpenAlex
- W2099365599
- Cited by
- 64
- References
- 24
- FWCI
- 6.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.